At Biogen Idec

We make it possible… to discover your career

As a global biotechnology leader, Biogen Idec is transforming scientific discovery into advances in healthcare by finding new biopharmaceutical therapies for unmet needs in the areas of oncology, neurology and immunology.

Employer of Choice

Biogen Idec is a financially strong organisation in the exciting world of pharmaceutical biotechnology. We currently employ approximately 4,000 people world wide, approaching 200 of which are in the UK.  We have a reputation for hiring the best.

Our employees enjoy a wide range of professional and personal development programmes as well as a working environment that supports discovery and encourages collaboration worldwide.

Consider the tremendous opportunities offered at Biogen Idec:

• Professional and personal growth and learning
• The satisfaction of helping to change people’s lives
• Stability of a financially strong organisation with a great pipeline
• Collaborative and enthusiastic work environment 
• Comprehensive benefits package

Our Products

Biogen Idec pursues the creativity of science with passion and discipline.  For nearly 30 years, the company has grown through the discovery, development and commercialisation of its own innovative products and through strategic alliances.  A strong pipeline of new medicines in both early and late stage development underlies our determination and commitment to continue delivering innovative medicines and services to patients in the years to come. Biogen Idec currently has over 20 products in clinical development addressing a variety of key medical needs.

Biogen Idec’s Global Infrastructure:
 

• Two centres of research excellence in Cambridge, MA and San Diego, CA.
• The UK hosts both our commercial activities and the International centre of excellence for R&D activities
• Three major manufacturing centres, in the US in Cambridge, MA and in North Carolina and in Europe in Hillerod, Denmark (on line in 2009)
• Additional offices in Canada, Australia, Japan and throughout Europe, including our site in Maidenhead, UK and our international headquarters in Zug, Switzerland
• $718 million spent in 2006 on research and development
• Global presence in over 25 countries and distribution in over 90 countries
• US based headquarters in Cambridge, MA. 

Financial Data

Exchange  NASDAQ
Ticker Symbol BIIB

2006 Revenue $2.7 billion 
Annual report